Bringing the fundamentals into focus…
Back to Lexeo Therapeutics, Inc.
How Lexeo Therapeutics, Inc. stacks up
LXEO · against 552 other Healthcare companies listed in US-listed
Overall
38/ 100
Below the middle of the pack.
Ranked #323 of 553 · scores higher than 39% of peers
Bars: peers in each 10-point band of the overall score142 peers with an overall score of 30–39, including LXEO · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around LXEO| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 323 | 285M USD | 38 | 33 | 8 | 21 | 0 / 2 | |
| 323 | 1.4B USD | 38 | 8 | — | 13 | 0 / 2 | |
| 323 | 22.8B USD | 38 | 8 | 95 | 14 | 1 / 2 | |
| 323 | 239M USD | 38 | 33 | 16 | 22 | 0 / 2 | |
| 323 | 255M USD | 38 | 8 | — | 17 | 0 / 2 | |
| 323 | 299M USD | 38 | 8 | — | 20 | 0 / 2 | |
| 323 | 1.6B USD | 38 | 8 | 95 | 18 | 2 / 2 | |
| 323 | 12M USD | 38 | 30 | 92 | 5 | 2 / 2 | |
| 323 | 5.7B USD | 38 | 44 | 9 | 86 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score